1. Metabolomic analysis of human plasma from haemodialysis patients
- Author
-
Masanori Yamamoto, Masahiro Kohno, Emiko Sato, Noriaki Tanaka, Tatsuya Fujisawa, and Kouichi Fujiwara
- Subjects
medicine.medical_specialty ,Creatinine ,business.industry ,Clinical Biochemistry ,Urology ,Case-control study ,Renal function ,General Medicine ,Biochemistry ,Surgery ,chemistry.chemical_compound ,Metabolomics ,chemistry ,Cohort ,medicine ,Analysis of variance ,Prospective cohort study ,business ,Cohort study - Abstract
Eur J Clin Invest 2011; 41 (3): 241–255 Abstract Background Urea and creatinine are widely used as biomarkers for disease. However, these parameters have been criticized as markers for several reasons. Thus, we conducted this study to identify novel biomarkers that can be used as alternatives to urea and creatinine to estimate the adequate dialysis dose by metabolomic analyses of plasma samples from patients undergoing haemodialysis. Material and methods Liquid chromatography–electrospray ionization (ESI)–time-of-flight mass spectrometry (MS) was used to analyse low molecular weight molecules present in the plasma samples of 10 patients with end-stage renal disease (ESRD) who were being treated with haemodialysis, and in 16 healthy subjects. Results In plasma samples obtained after haemodialysis, the relative quantities of 54 peaks were significantly (P
- Published
- 2010
- Full Text
- View/download PDF